Literature DB >> 6831342

Branhamella catarrhalis conjunctivitis.

J Righter, G Nicol.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6831342      PMCID: PMC1875403     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Neonatal conjunctivitis.

Authors:  E I Tanner
Journal:  Br Med J       Date:  1972-05-27

2.  Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.

Authors:  J E Brorson; J Martinell; H Wilske
Journal:  J Antimicrob Chemother       Date:  1981-02       Impact factor: 5.790

Review 3.  Are the "nonpathogenic" Neisseriae pathogenic?

Authors:  D A Herbert; J Ruskin
Journal:  Am J Clin Pathol       Date:  1981-05       Impact factor: 2.493

4.  Pseudogonococcal ophthalmia neonatorum. Branhamella (Neisseria) catarrhalis conjunctivitis.

Authors:  R P Spark; P W Dahlberg; J W LaBelle
Journal:  Am J Clin Pathol       Date:  1979-09       Impact factor: 2.493

5.  Ophthalmia neonatorum: a chart review.

Authors:  J H Armstrong; F Zacarias; M F Rein
Journal:  Pediatrics       Date:  1976-06       Impact factor: 7.124

6.  Ophthalmia neonatorum due to Branhamella (Neisseria) catarrhalis. Case reports.

Authors:  R J Garvey; T A Reed
Journal:  Br J Vener Dis       Date:  1981-10

7.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

8.  Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis.

Authors:  M Leinonen; J Luotonen; E Herva; K Valkonen; P H Mäkelä
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

  8 in total
  3 in total

Review 1.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 2.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

3.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.